These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 4359197)
1. Hodgkin's disease: involvement of viral agents in the etiology. Sinkovics JG; Györkey F J Med; 1973; 4(5):282-317. PubMed ID: 4359197 [No Abstract] [Full Text] [Related]
2. [Modern views on the viral etiology of Hodgkin's disease]. Knap J Pol Arch Med Wewn; 1970 Nov; 45(5):697-703. PubMed ID: 4321189 [No Abstract] [Full Text] [Related]
3. [Hodgkin's-like animal reticulopathies. Their significance for the study of human disease]. Hoerni B; Legrand E; Chauvergne J Bull Cancer; 1970; 57(1):37-54. PubMed ID: 4915948 [No Abstract] [Full Text] [Related]
4. International symposium on Hodgkin's disease. Session 2. Histopathology and experimental cytology. Invited discussion: Synthesis and implications for the etiology, pathogenesis and spread of Hodgkin's disease. Berard CW Natl Cancer Inst Monogr; 1973 May; 36():261-3. PubMed ID: 4355349 [No Abstract] [Full Text] [Related]
5. Pathogenesis of Hodgkin's disease. Order SE; Hellman S Lancet; 1972 Mar; 1(7750):571-3. PubMed ID: 4110054 [No Abstract] [Full Text] [Related]
6. Evidence for environmental factors in the etiology of Hodgkin's disease. Newell GR; Rawlings W J Chronic Dis; 1972 May; 25(5):261-7. PubMed ID: 4344837 [No Abstract] [Full Text] [Related]
7. Possible viral etiology of human cancer. Feller WF Surg Annu; 1973; 5():31-53. PubMed ID: 4367762 [No Abstract] [Full Text] [Related]
8. Correlation between mixed lymphocyte cultures and anti-Epstein Barr virus (EBV) antibodies in Hodgkin's disease and non Hodgkin lymphoma patients. Sasiain MC; Fejes M; Ares BR; Brezavscek D; Bachmann AE Biomedicine; 1981 Oct; 35(5):153-6. PubMed ID: 6274439 [TBL] [Abstract][Full Text] [Related]
9. New vistas in Hodgkin's disease. Ioachim HL Pathol Annu; 1975; 10():419-59. PubMed ID: 170577 [No Abstract] [Full Text] [Related]
10. Hodgkin's disease: the remaining challenge. Diehl V; Burrichter H; Schaadt M; Fonatsch C; Stein H; Rossbach HC Prog Med Virol; 1984; 30():199-203. PubMed ID: 6087413 [No Abstract] [Full Text] [Related]
12. In search of a Hodgkin's disease virus. Gallo RC; Gelmann EP N Engl J Med; 1981 Jan; 304(3):169-70. PubMed ID: 6255330 [No Abstract] [Full Text] [Related]
13. [Immunological aspects of lymphogranulomatosis]. Blokhina NG; Agafonov VA; Bykovskaia SN; Naumova ER; Raushenbakh MO Ter Arkh; 1984; 56(10):125-30. PubMed ID: 6098042 [No Abstract] [Full Text] [Related]
14. [Immunologic deficit in Hodgkin's disease. Clinical reflections and pathogenetic implications]. Maggi E; Romagnani S; Ricci M Ann Ital Med Int; 1986 Mar; 1(1):54-65. PubMed ID: 3079355 [No Abstract] [Full Text] [Related]
15. Hodgkin's disease: considerable progress and more to be achieved. Mathé G; Tubiana M Ser Haematol; 1973; 6(2):244-69. PubMed ID: 4361523 [No Abstract] [Full Text] [Related]
16. Production of spleen focus-forming virus and murine leukemia virus by early erythroblasts after Friend virus infection. Kost TA; Hankins WD; Glick AD; Krantz SB Cancer Res; 1980 Apr; 40(4):1150-6. PubMed ID: 6244087 [No Abstract] [Full Text] [Related]
17. [Passive protection by interferon of mice infected with the viral agent isolated from Hodgkin's disease]. Danielescu G; Cajal N; Cepleanu M; Sorodoc Y; Lotreanu V Stud Cercet Inframicrobiol; 1965; 16(4):317-22. PubMed ID: 5864431 [No Abstract] [Full Text] [Related]